sulfasalazine has been researched along with Arthritis, Spinal in 22 studies
Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To assess the effect of sulfasalazine (SSZ) on inflammatory back pain (IBP) due to active undifferentiated spondyloarthritis (uSpA) or ankylosing spondylitis in patients with symptom duration <5 years." | 9.12 | Efficacy of sulfasalazine in patients with inflammatory back pain due to undifferentiated spondyloarthritis and early ankylosing spondylitis: a multicentre randomised controlled trial. ( Alten, R; Baraliakos, X; Baumgaertner, M; Beck, E; Brandt, J; Braun, J; Burmester, G; Ebner, W; Gömör, B; Grasedyck, K; Haibel, H; Hammer, M; Hermann, J; Krause, A; Mielke, F; Sieper, J; Tony, HP; Zeidler, H; Zochling, J, 2006) |
| "Sulfasalazine has been widely used in treatment of rheumatoid arthritis and spondyloarthritis." | 8.12 | Adverse reaction profile of sulfasalazine and its persistence in chronic therapy of rheumatoid arthritis and spondyloarthritis: A multicentric observational study. ( David, R; Jayachandran, M; Koshy, V; Marwaha, V; Mithun, CB; Nair, AS; Padmanabhan, DS; Palatty, PL; Santhakumari, V; Singh, SK; Singhal, A; Suman, SK; Surendran, S; Tiwari, A; Yadav, P, 2022) |
| "To assess the effect of sulfasalazine (SSZ) on inflammatory back pain (IBP) due to active undifferentiated spondyloarthritis (uSpA) or ankylosing spondylitis in patients with symptom duration <5 years." | 5.12 | Efficacy of sulfasalazine in patients with inflammatory back pain due to undifferentiated spondyloarthritis and early ankylosing spondylitis: a multicentre randomised controlled trial. ( Alten, R; Baraliakos, X; Baumgaertner, M; Beck, E; Brandt, J; Braun, J; Burmester, G; Ebner, W; Gömör, B; Grasedyck, K; Haibel, H; Hammer, M; Hermann, J; Krause, A; Mielke, F; Sieper, J; Tony, HP; Zeidler, H; Zochling, J, 2006) |
| "Sulfasalazine has been widely used in treatment of rheumatoid arthritis and spondyloarthritis." | 4.12 | Adverse reaction profile of sulfasalazine and its persistence in chronic therapy of rheumatoid arthritis and spondyloarthritis: A multicentric observational study. ( David, R; Jayachandran, M; Koshy, V; Marwaha, V; Mithun, CB; Nair, AS; Padmanabhan, DS; Palatty, PL; Santhakumari, V; Singh, SK; Singhal, A; Suman, SK; Surendran, S; Tiwari, A; Yadav, P, 2022) |
| "A FREQUENT AFFECTION: Ankylosing spondylitis is a chronic inflammatory rheumatism usually affecting young adults and characterized by an inflammatory enthesiopathy progressing towards ossification and ankylosis." | 2.42 | [Ankylosing spondylitis]. ( El Maghraoui, A, 2004) |
| "Age and uveitis are related to conversion to biologics therapy." | 1.91 | Cause analysis of conversion to biologics in spondyloarthritis patients with poor response to conventional treatment. ( Huang, D; Huang, W; Luo, L; Ren, F; Tang, L; Zhang, Z; Zhou, J, 2023) |
| "Sacroiliitis is an important sign of spondylarthritis (SpA) of which the prototype disease is ankylosing spondylitis." | 1.35 | Efficacy of SLZ and MTX (alone or combination) on the treatment of active sacroiliitis in early AS. ( Argin, M; Gumusdis, G; Kabasakal, Y; Kitapcioglu, G; Taylan, A; Yargucu, F, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (18.18) | 29.6817 |
| 2010's | 11 (50.00) | 24.3611 |
| 2020's | 7 (31.82) | 2.80 |
| Authors | Studies |
|---|---|
| Khellaf, L | 1 |
| Cosserat, J | 1 |
| Calas, A | 1 |
| Brasme, H | 1 |
| Charles, P | 1 |
| Caterson, HC | 1 |
| Youssef, P | 1 |
| Jayachandran, M | 1 |
| Koshy, V | 1 |
| David, R | 1 |
| Santhakumari, V | 1 |
| Padmanabhan, DS | 1 |
| Surendran, S | 1 |
| Tiwari, A | 1 |
| Mithun, CB | 1 |
| Singh, SK | 1 |
| Suman, SK | 1 |
| Yadav, P | 1 |
| Singhal, A | 1 |
| Nair, AS | 1 |
| Marwaha, V | 1 |
| Palatty, PL | 1 |
| G S Saad, C | 1 |
| S R Silva, M | 1 |
| Sampaio-Barros, PD | 1 |
| C B Moraes, J | 1 |
| G Schainberg, C | 1 |
| Gonçalves, CR | 1 |
| Shimabuco, AY | 1 |
| Aikawa, NE | 1 |
| F N Yuki, E | 1 |
| G Pasoto, S | 1 |
| V K Kupa, L | 1 |
| K Aoyama, R | 1 |
| S R Araujo, C | 1 |
| Silva, CA | 1 |
| Medeiros-Ribeiro, AC | 1 |
| Bonfa, E | 1 |
| Armağan, B | 1 |
| Atalar, E | 1 |
| Güven, SC | 1 |
| Özdemir, B | 1 |
| Konak, HE | 1 |
| Akyüz Dağlı, P | 1 |
| Erden, A | 1 |
| Gök, K | 1 |
| Maraş, Y | 1 |
| Doğan, İ | 1 |
| Küçükşahin, O | 1 |
| Erten, Ş | 1 |
| Omma, A | 1 |
| Zhou, J | 1 |
| Huang, W | 1 |
| Zhang, Z | 1 |
| Luo, L | 1 |
| Ren, F | 1 |
| Huang, D | 1 |
| Tang, L | 1 |
| Ganapati, A | 1 |
| Gowri, M | 1 |
| Antonisamy, B | 1 |
| Danda, D | 1 |
| Banse, C | 1 |
| Armengol-Debeir, L | 1 |
| Vittecoq, O | 1 |
| Felice, C | 1 |
| Pugliese, D | 1 |
| Papparella, LG | 1 |
| Pizzolante, F | 1 |
| Onori, E | 1 |
| Gasbarrini, A | 1 |
| Rapaccini, GL | 1 |
| Guidi, L | 1 |
| Armuzzi, A | 1 |
| John, KJ | 1 |
| Sadiq, M | 1 |
| Thomas, M | 1 |
| Turaka, VP | 1 |
| Krohn, M | 1 |
| Braum, LS | 1 |
| Sieper, J | 5 |
| Song, IH | 3 |
| Weiss, A | 2 |
| Callhoff, J | 1 |
| Althoff, CE | 3 |
| Hamm, B | 1 |
| Hermann, KG | 2 |
| Fagerli, KM | 1 |
| van der Heijde, D | 1 |
| Heiberg, MS | 1 |
| Wierød, A | 1 |
| Kalstad, S | 1 |
| Rødevand, E | 1 |
| Mikkelsen, K | 1 |
| Kvien, TK | 1 |
| Lie, E | 2 |
| Kristensen, LE | 1 |
| Forsblad-d'Elia, H | 1 |
| Zverkova-Sandström, T | 1 |
| Askling, J | 1 |
| Jacobsson, LT | 1 |
| Kabasakal, Y | 1 |
| Kitapcioglu, G | 1 |
| Yargucu, F | 1 |
| Taylan, A | 1 |
| Argin, M | 1 |
| Gumusdis, G | 1 |
| Karmakar, GC | 1 |
| Wong, CA | 1 |
| Horwood, F | 1 |
| Anderson, G | 1 |
| Hermann, K | 1 |
| Haibel, H | 3 |
| Althoff, C | 1 |
| Listing, J | 2 |
| Burmester, G | 2 |
| Krause, A | 2 |
| Bohl-Bühler, M | 1 |
| Freundlich, B | 2 |
| Rudwaleit, M | 2 |
| Poddubnyy, D | 1 |
| Tayel, MY | 1 |
| Soliman, E | 1 |
| El Baz, WF | 1 |
| El Labaan, A | 1 |
| Hamaad, Y | 1 |
| Ahmed, MH | 1 |
| Castro Villegas, Mdel C | 1 |
| Escudero Contreras, A | 1 |
| Miranda García, MD | 1 |
| Collantes Estévez, E | 1 |
| El Maghraoui, A | 1 |
| Braun, J | 2 |
| Zochling, J | 1 |
| Baraliakos, X | 1 |
| Alten, R | 1 |
| Grasedyck, K | 1 |
| Brandt, J | 1 |
| Hammer, M | 1 |
| Mielke, F | 1 |
| Tony, HP | 1 |
| Ebner, W | 1 |
| Gömör, B | 1 |
| Hermann, J | 1 |
| Zeidler, H | 1 |
| Beck, E | 1 |
| Baumgaertner, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Immunogenicity and Safety of the CoronaVac Vacccine in Patients With Autoimmune Rheumatic Diseases and People Living With HIV/AIDS[NCT04754698] | Phase 4 | 2,067 participants (Anticipated) | Interventional | 2021-02-09 | Active, not recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
4 reviews available for sulfasalazine and Arthritis, Spinal
| Article | Year |
|---|---|
Effectiveness of vedolizumab for Crohn's disease with spondyloarthritis in fail with two TNF blocking agents.
Topics: Adrenal Cortex Hormones; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Crohn Dis | 2018 |
Clinical management of rheumatologic conditions co-occurring with inflammatory bowel diseases.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal, Humanized; Evidence-Based | 2018 |
[How to optimize the antiTNF alpha therapy in spondylitis?].
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antirheu | 2012 |
[Ankylosing spondylitis].
Topics: Acquired Hyperostosis Syndrome; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; A | 2004 |
5 trials available for sulfasalazine and Arthritis, Spinal
13 other studies available for sulfasalazine and Arthritis, Spinal
| Article | Year |
|---|---|
Unusual neurological and cardiac complications of drug reaction with eosinophilia and systemic symptoms syndrome: a case report.
Topics: Adrenal Cortex Hormones; Aged; Anti-Inflammatory Agents, Non-Steroidal; Brain Ischemia; Drug Hyperse | 2021 |
Sulfasalazine-induced myopathy in a patient with an acute spondyloarthritis.
Topics: Antirheumatic Agents; Humans; Muscular Diseases; Spondylarthritis; Sulfasalazine | 2022 |
Adverse reaction profile of sulfasalazine and its persistence in chronic therapy of rheumatoid arthritis and spondyloarthritis: A multicentric observational study.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Drug Therapy, Combination; Drug-Related Side Effects an | 2022 |
Effects of sulfasalazine in axial spondyloarthritis on COVID-19 outcomes: real-life data from a single center.
Topics: Axial Spondyloarthritis; Biological Products; COVID-19; Female; Humans; Male; Middle Aged; Retrospec | 2023 |
Cause analysis of conversion to biologics in spondyloarthritis patients with poor response to conventional treatment.
Topics: Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Biological Factors; Biolo | 2023 |
Combination of methotrexate and sulfasalazine is an efficacious option for axial spondyloarthritis in a resource-limited, real-world clinical setting: a prospective cohort study.
Topics: Antirheumatic Agents; Cohort Studies; Humans; Methotrexate; Prospective Studies; Spondylarthritis; S | 2021 |
Henoch-Schonlein purpura associated with HLA-B27 positive axial spondyloarthritis in a young man.
Topics: Abdominal Pain; Adult; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; HLA-B27 Antige | 2019 |
Is there a role for sulphasalazine in axial spondyloarthritis in the era of TNF inhibition? Data from the NOR-DMARD longitudinal observational study.
Topics: Adult; Antirheumatic Agents; Biological Products; Drug Substitution; Female; Humans; Kaplan-Meier Es | 2014 |
The effect of comedication with conventional synthetic disease modifying antirheumatic drugs on TNF inhibitor drug survival in patients with ankylosing spondylitis and undifferentiated spondyloarthritis: results from a nationwide prospective study.
Topics: Adalimumab; Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antirheumatic Agents; | 2015 |
Efficacy of SLZ and MTX (alone or combination) on the treatment of active sacroiliitis in early AS.
Topics: Adult; Antirheumatic Agents; Drug Therapy, Combination; Female; Humans; Magnetic Resonance Imaging; | 2009 |
Sulphasalazine lung toxicity: report of two cases.
Topics: Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Bronchiectasis; Cough; Crohn Disease; Female; Hu | 2010 |
Registry of the clinical characteristics of spondyloarthritis in a cohort of Egyptian population.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Cohort Studies; Cross-Sectional Studies; Disability | 2012 |
[Spondylarthritides].
Topics: Adalimumab; Adult; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Antibodies, Mono | 2006 |